Agilent Technologies Inc at JPMorgan Healthcare Conference Transcript
All right. Good afternoon, everybody. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this afternoon, Agilent. Just a quick reminder to everybody, if you have questions, you can submit them through the website.
And with that, let me turn it over to Mike.
Hey, thanks, Tycho. It's a real pleasure to be here. Now I'm sure, like all of us, we had hoped to perhaps be doing this conversation face-to-face, but just delighted that you could join us today in this virtual event for me to share with you the updated Agilent story. And it's a really exciting story. We just finished off our 2021 with record performance and entered the 2022 environment with a lot of momentum. So I thought what we would do today is cover 3 topics.
I would like to open up with just a reminder, on the Agilent shareholder value creation model, our results delivered to date
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
